Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist - Tecle_1998_J.Med.Chem_41_2524 |
Author(s) : Tecle H , Barrett SD , Lauffer DJ , Augelli-Szafran C , Brann MR , Callahan MJ , Caprathe BW , Davis RE , Doyle PD , Eubanks D , Lipiniski W , Mirzadegan T , Moos WH , Moreland DW , Nelson CB , Pavia MR , Raby C , Schwarz RD , Spencer CJ , Thomas AJ , Jaen JC |
Ref : Journal of Medicinal Chemistry , 41 :2524 , 1998 |
Abstract : Tecle_1998_J.Med.Chem_41_2524 |
ESTHER : Tecle_1998_J.Med.Chem_41_2524 |
PubMedSearch : Tecle_1998_J.Med.Chem_41_2524 |
PubMedID: 9651157 |
Title : Cholinergic therapies for Alzheimer's disease. Palliative or disease altering? - Davis_1995_Arzneimittelforschung_45_425 |
Author(s) : Davis RE , Doyle PD , Carroll RT , Emmerling MR , Jaen J |
Ref : Arzneimittelforschung , 45 :425 , 1995 |
Abstract : Davis_1995_Arzneimittelforschung_45_425 |
ESTHER : Davis_1995_Arzneimittelforschung_45_425 |
PubMedSearch : Davis_1995_Arzneimittelforschung_45_425 |
PubMedID: 7763338 |